Sequent Scientific Limited
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more
Sequent Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.051x
Based on the latest financial reports, Sequent Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹449.00 Million) by net assets (₹8.87 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sequent Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Sequent Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sequent Scientific Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sequent Scientific Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Weide Information Technology Co. Ltd. A
SHG:688171
|
-0.013x |
|
FIC Global Inc
TW:3701
|
0.069x |
|
Huadian Ener-B
SHG:900937
|
0.067x |
|
Abacus Life Inc.
NASDAQ:ABL
|
-0.075x |
|
SI-TECH Information Technology Co Ltd
SHE:300608
|
-0.043x |
|
Guangdong Shunkong Development Co Ltd
SHE:003039
|
0.047x |
|
Kempower Oyj
HE:KEMPOWR
|
0.030x |
|
Greentown Management Holdings Company Limited
PINK:GRMHF
|
0.030x |
Annual Cash Flow Conversion Efficiency for Sequent Scientific Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Sequent Scientific Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹7.70 Billion | ₹833.60 Million | 0.108x | +152.16% |
| 2024-03-31 | ₹7.13 Billion | ₹305.95 Million | 0.043x | +91.28% |
| 2023-03-31 | ₹7.49 Billion | ₹168.08 Million | 0.022x | -45.73% |
| 2022-03-31 | ₹7.40 Billion | ₹305.95 Million | 0.041x | -72.03% |
| 2021-03-31 | ₹7.76 Billion | ₹1.15 Billion | 0.148x | -6.20% |
| 2020-03-31 | ₹7.32 Billion | ₹1.15 Billion | 0.158x | +1.45% |
| 2019-03-31 | ₹7.47 Billion | ₹1.16 Billion | 0.155x | +135.05% |
| 2018-03-31 | ₹6.85 Billion | ₹452.39 Million | 0.066x | +1013.61% |
| 2017-03-31 | ₹9.94 Billion | ₹-71.90 Million | -0.007x | -12597.48% |
| 2016-03-31 | ₹9.48 Billion | ₹-540.00K | 0.000x | +99.94% |
| 2015-03-31 | ₹2.38 Billion | ₹-235.49 Million | -0.099x | +86.47% |
| 2014-03-31 | ₹613.06 Million | ₹-447.85 Million | -0.731x | -1803.87% |
| 2013-03-31 | ₹995.83 Million | ₹-38.21 Million | -0.038x | -116.25% |
| 2012-03-31 | ₹1.28 Billion | ₹302.36 Million | 0.236x | -37.08% |
| 2011-03-31 | ₹1.35 Billion | ₹506.60 Million | 0.375x | +148.36% |
| 2010-03-31 | ₹1.12 Billion | ₹168.95 Million | 0.151x | +223.00% |
| 2009-03-31 | ₹405.20 Million | ₹-49.79 Million | -0.123x | -14561.60% |
| 2008-03-31 | ₹573.71 Million | ₹487.47K | 0.001x | -99.26% |
| 2007-03-31 | ₹349.24 Million | ₹40.21 Million | 0.115x | -68.51% |
| 2006-03-31 | ₹198.08 Million | ₹72.43 Million | 0.366x | -- |